SOURCES SOUGHT
66 -- Multi-Channel Adaptive Optics Lens, with 16 Actuators
- Notice Date
- 7/17/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-RFQ-2014-1134609
- Archive Date
- 8/7/2014
- Point of Contact
- Emmanuel T. Mbah,
- E-Mail Address
-
Emmanuel.mbah@fda.hhs.gov
(Emmanuel.mbah@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION - FDA-RFQ-2014-1134609 SUBJECT: Multi-Channel Adaptive Optics Lens, with 16 Actuators. The U. S Food & Drug Administration, Office of Acquisitions and Grants Services has a requirement for the purchase of Multi-Channel Adaptive Optics Lens, with 16 Actuators. This is a sources sought notice to determine the availability and capability of small business manufacturers or small businesses capable of providing a Multi-Channel Adaptive Optics Lens, with 16 Actuators. The associated NAICS Code is: 334516 Analytical Laboratory Instrument Manufacturing. Background: The requested multi-channel adaptive lens is for use in the development of a model eye for evaluation of adaptive optics imaging systems. This purchase is part of a broader research effort by FDA/OSEL/DP in the development of phantom-based approaches for evaluation of the effectiveness of optical imaging technologies that are part of medical devices. Specific requirements are as follows: The requested instrument must have the following salient characteristics and specifications: • At a minimum, the requested instrument must have: 16 actuators or more, with o Generation of up to 4 orders (Zernick) of aberrations. o Stroke of 10 µm or more. • At a minimum, the clear aperture of the requested instrument must be: 10 mm or less. • The requested instrument must have a Visible-NIR light transmission • At a minimum, the voltage driver of the requested instrument must have: o Update rate: 100 Hz or greater. o Drive voltage: -125V/+125V. o Power: 120 VAC. Location of Work: The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition, at the following address: Food and Drug Administration (FDA) FDA/CDRH/OSEL/DP 10903 New Hampshire Avenue Building 62, Room 1106 Silver Spring, MD 20993 Responses to this sources sought notice shall unequivocally demonstrate that the respondent is regularly engaged in the manufacture and/or sale of same or substantially similar items. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer, all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; [Provide this same information again if responding to provide a product manufactured by another firm.] • Three (3) years of past performance information for the manufacture and/or sale of same or substantially similar items to include date of sale, description (should also include drawings and photos), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, marketing material, etc. detailing the nature of the items the responding firm is regularly engaged in manufacturing and/or selling; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify the subcontracting opportunities that would exist for small business concerns; and • Though this is not a request for quote, informational pricing is encouraged. The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before July 23rd, 2014 by 12:00 P. M Est) at the Food and Drug Administration, Attn: Emmanuel T. Mbah, 5630 Fishers Lane, Room 2142, Rockville, MD 20857 or email Emmanuel.mbah@fda.hhs.gov. Reference: 1120158. Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small businesses, made available to full and open competition or procured through sole-source acquisition procedures. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-RFQ-2014-1134609/listing.html)
- Place of Performance
- Address: Food and Drug Administration (FDA), FDA/CDRH/OSEL/DP, 10903 New Hampshire Avenue, Building 62, Room 1106, Silver Spring, MD 20993, Silver spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN03429583-W 20140719/140718000206-06b42facf12ec7fc697c3ab4eb628c2c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |